Johnson and Johnson Gets CDSCO Panel nod for Additional Indication of Ustekinumab solution for injection Dr. Divya Colin4 May 2025 5:15 PM ISTNew Delhi: The Subject Expert Committee (SEC), functional under the Central Drug Standard Control Organization (CDSCO), has granted approval to...
FDA Approves Nipocalimab for Generalized Myasthenia Gravis Dr. Kamal Kant Kohli1 May 2025 7:00 AM ISTThe US Food and Drug Administration (FDA) has approved nipocalimab (Imaavy) injection for the treatment of adults and children aged 12 and older with...
CARE Hospitals launches AI-powered non-invasive therapy Jyoti bhatia3 April 2025 12:10 PM ISTHyderabad: CARE Hospitals, a renowned healthcare provider, on Tuesday announced the launch of an ‘AI-powered, non-invasive therapy’ programme in...
Johnson and Johnson Wins Rs 3.34 Crore Lawsuit Against Fake SURGICEL, ETHICON Sellers Farhat Nasim12 March 2025 9:16 PM ISTNew Delhi: The Delhi High Court has ruled in favor of Johnson & Johnson (J&J), awarding the company Rs 3.34 crore in damages against Medserve...
CDSCO Panel Approves Johnson and Johnson's Protocol Amendment proposal for Teclistamab study Dr. Divya Colin2 March 2025 5:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved Johnson and...
Johnson and Johnson Gets CDSCO Panel Nod To study Guselkumab in Psoriatic Arthritis Dr. Divya Colin17 Feb 2025 5:00 PM ISTNew Delhi: Pharmaceutical major Johnson and Johnson has got the go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug...
FDA Approves Esketamine Nasal Spray for Treatment-Resistant Depression Dr. Kamal Kant Kohli22 Jan 2025 8:45 PM ISTThe FDA has approved esketamine (Spravato) nasal spray as a monotherapy for adults with treatment-resistant depression. This approval applies to...
Health Ministry Reconstitutes Expert Panel for J&J ASR Hip Implant Compensation Farhat Nasim6 Dec 2024 4:06 PM ISTNew Delhi: The Ministry of Health and Family Welfare has reconstituted its Central Expert Committee to address compensation issues concerning faulty...
Icotrokinra shows impressive results in moderate to severe plaque psoriasis in phase 3 trial Dr. Kamal Kant Kohli23 Nov 2024 6:00 AM ISTIcotrokinra is an investigational oral peptide that blocks interleukin (IL)-23 receptor, which plays a significant role in the pathogenesis of...
Johnson & Johnson Gets CDSCO Panel Nod to Study anti-cancer drug Amivantamab Dr. Divya Colin26 Oct 2024 5:30 PM ISTNew Delhi: The drug major Johnson & Johnson has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Johnson & Johnson ordered to pay Rs 128 crore to man claiming its baby powder caused his cancer MD Bureau16 Oct 2024 1:20 PM ISTPlaintiff Evan Plotkin sued the company in 2021 soon after his diagnosis, saying he was sickened by inhaling JnJ's baby powder.
J&J talc bankruptcy stays in Texas despite 'forum-shopping' opposition MD Bureau Team13 Oct 2024 12:48 PM ISTNew York: A Johnson & Johnson subsidiary can pursue its third attempt to resolve tens of thousands of lawsuits alleging its talc...
